UIH(688271) 搜狐财经·2025-04-17 11:15Core Viewpoint - 联影医疗's stock closed at 130.89 yuan, down 1.58%, with a rolling PE ratio of 85.49 times, significantly higher than the industry average of 44.77 times [1][2] Company Summary - 联影医疗 focuses on providing high-performance medical imaging equipment, radiation therapy products, life science instruments, and digital healthcare solutions globally [1] - The company has made substantial investments in R&D, leading to a comprehensive product line that includes medical imaging devices and radiation therapy products [1] - It has undertaken nearly 40 national and provincial R&D projects, including around 20 major national science and technology projects, and has received numerous awards for its innovations [1] Financial Performance - In the latest Q3 2024 report, the company achieved a revenue of 69.54 billion yuan, a year-on-year decrease of 6.43%, and a net profit of 6.71 billion yuan, down 36.94% [2] - The gross profit margin for the company stands at 49.41% [2] Market Position - As of the Q3 2024 report, 551 institutions hold shares in 联影医疗, with a total shareholding of 13,321.64 million shares valued at 16.839 billion yuan [1] - The company's total market capitalization is 107.874 billion yuan, ranking it 106th in the medical device industry based on PE ratio [1][2]